ConCallIQ
Go Pro
MEDANTA Diversified 2026-05-??

Global Health Limited — Q4 FY26

Global Health (Medanta) reported a strong Q4 FY26 with revenue of ₹1,196 crore (+25% YoY) and PAT of ₹147 crore (+14% YoY), driven by robust volume growth (IPD +23%, OPD +27%) a...

bullish high
Compare with...
Revenue ₹1,159 Cr +25%
EBITDA ₹296 Cr +17%
PAT ₹142 Cr +14%
EBITDA Margin 21%
Duration 69 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Competitive intensity in Gurugram

New hospitals opening in Gurugram could increase competition for patients and clinical talent, potentially impacting occupancy and margins.

medium · analyst_question
R

Noida ramp-up slower than expected

Noida's breakeven timeline depends on occupancy reaching 40-45%; delays in empanelments or patient flow could extend losses.

medium · management_commentary
R

Middle East geopolitical risks

International patient revenue faces short-term challenges due to the situation in the Middle East, which could impact growth.

low · management_commentary
R

Greenfield project execution delays

Large greenfield projects (Delhi, Mumbai) may take 3+ years, with potential delays in regulatory approvals or construction, pushing revenue contribution beyond FY30.

medium · analyst_question